Potential Treatment of Parkinson’S Disease Using New-Generation Carbon Nanotubes: A Biomolecular In Silico Study

References

• Stephenson J , NutmaE, VanDer Valk P, AmorS. Inflammation in CNS neurodegenerative diseases. Immunology154(2), 204–219 (2018).
   PubMed Web of Science ®Google Scholar
• Dickson DW . Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harbor Perspect. Med.2(8), a009258 (2012).
   PubMed Web of Science ®Google Scholar
• Kordower JH , OlanowCW, DodiyaHBet al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain136(8), 2419–2431 (2013).
   PubMedGoogle Scholar
• Nomoto M , IwakiH, TagawaM, IwasakiK. Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms. J. Neurol. Sci.405, 24–25 (2019).
   Web of Science ®Google Scholar
• Cheong SL , FedericoS, SpallutoG, KlotzK-N, PastorinG. The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy. Drug Discov. Today24(9), 1769–1783 (2019).
   PubMed Web of Science ®Google Scholar
• Stanković I , PetrovićI, PekmezovićTet al. Longitudinal assessment of autonomic dysfunction in early Parkinson's disease. Parkinsonism Related Disord.66, 74–79 (2019).
   PubMed Web of Science ®Google Scholar
• Amara AW , MemonAA. Effects of exercise on non-motor symptoms in Parkinson's disease. Clin. Ther.40(1), 8–15 (2018).
   PubMed Web of Science ®Google Scholar
• Seppi K , RayChaudhuri K, CoelhoMet al. Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence-based medicine review. Movement Disord.34(2), 180–198 (2019).
   PubMed Web of Science ®Google Scholar
• Soto C , PritzkowS. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci.21(10), 1332–1340 (2018).
   PubMed Web of Science ®Google Scholar
• Ulmer TS , BaxA, ColeNB, NussbaumRL. Structure and dynamics of micelle-bound human α-synuclein. J. Biol. Chem.280(10), 9595–9603 (2005).
   PubMed Web of Science ®Google Scholar
• Mukaetova-Ladinska EB , MckeithIG. Pathophysiology of synuclein aggregation in Lewy body disease. Mech. Ageing Dev.127(2), 188–202 (2006).
   PubMed Web of Science ®Google Scholar
• Palazzi L , BruzzoneE, BiselloGet al. Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates. Sci. Rep.8(1), 1–17 (2018).
   PubMedGoogle Scholar
• Do J , MckinneyC, SharmaP, SidranskyE. Glucocerebrosidase and its relevance to Parkinson disease. Mol. Neurodegen.14(1), 36 (2019).
   PubMed Web of Science ®Google Scholar
• Gallegos S , PachecoC, PetersC, OpazoCM, AguayoLG. Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease. Front. Neurosci.9, 59 (2015).
   PubMed Web of Science ®Google Scholar
• Mohammad-Beigi H , HosseiniA, AdeliMet al. Mechanistic understanding of the interactions between nano-objects with different surface properties and α-synuclein. ACS Nano13(3), 3243–3256 (2019).
   PubMed Web of Science ®Google Scholar
• Kim D , YooJM, HwangHet al. Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease. Nat. Nanotechnol.13(9), 812–818 (2018).
   PubMed Web of Science ®Google Scholar
• Alimohammadi E , KhedriM, JahromiAM, MalekiR, RezaianM. Graphene-Based nanoparticles as potential treatment options for Parkinson's disease: a molecular dynamics study. Int. J. Nanomed.15, 6887 (2020).
   PubMed Web of Science ®Google Scholar
• ALvarez YD , FauerbachJA, PellegrottiJSV, JovinTM, Jares-ErijmanEA, StefaniFD. Influence of gold nanoparticles on the kinetics of α-synuclein aggregation. Nano Lett.13(12), 6156–6163 (2013).
   PubMed Web of Science ®Google Scholar
• Hubbard RE , HaiderMK. Hydrogen bonds in proteins: role and strength. eLS doi: 10.1002/9780470015902.a0003011.pub2 (2010) ( Epub ahead of print).
   Google Scholar
• Xing R , YuanC, LiS, SongJ, LiJ, YanX. Charge-induced secondary structure transformation of amyloid-derived dipeptide assemblies from β-sheet to α-helix. Angew. Chem. Int. Ed.57(6), 1537–1542 (2018).
   PubMed Web of Science ®Google Scholar
• Mahajan S , PatharkarA, KucheKet al. Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer. Int. J. Pharm.548(1), 540–558 (2018).
   PubMed Web of Science ®Google Scholar
• Simon J , FlahautE, GolzioM. Overview of carbon nanotubes for biomedical applications. Materials12(4), 624 (2019).
   PubMed Web of Science ®Google Scholar
• Saliev T . The advances in biomedical applications of carbon nanotubes. C J. Carbon Res.5(2), 29 (2019).
   Web of Science ®Google Scholar
• Raphey V , HennaT, NivithaK, MufeedhaP, SabuC, PramodK. Advanced biomedical applications of carbon nanotube. Mater. Sci. Eng. C100, 616–630 (2019).
   PubMed Web of Science ®Google Scholar
• Taebnia N , MorshediD, DoostkamMet al. The effect of mesoporous silica nanoparticle surface chemistry and concentration on the α-synuclein fibrillation. RSC Adv.5(75), 60966–60974 (2015).
   Web of Science ®Google Scholar
• Taebnia N , MorshediD, YaghmaeiS, AliakbariF, RahimiF, ArpanaeiA. Curcumin-loaded amine-functionalized mesoporous silica nanoparticles inhibit α-synuclein fibrillation and reduce its cytotoxicity-associated effects. Langmuir32(50), 13394–13402 (2016).
   PubMed Web of Science ®Google Scholar
• Frenkel D , SmitB, TobochnikJ, MckaySR, ChristianW. Understanding molecular simulation. Comput. Phys.11(4), 351–354 (1997).
   Google Scholar
• Rapaport DC . The Art of Molecular Dynamics Simulation.Cambridge University Press, Cambrigde, UK, (2004).
   Google Scholar
• Huang J , LemkulJA, EastmanPK, MackerellADJr. Molecular dynamics simulations using the drude polarizable force field on GPUs with OpenMM: implementation, validation, and benchmarks. J. Computat. Chem.39(21), 1682–1689 (2018).
   PubMed Web of Science ®Google Scholar
• Lemak A , BalabaevN. On the Berendsen thermostat. Mol. Simulat.13(3), 177–187 (1994).
   Web of Science ®Google Scholar
• Kulakova L , ArampatzisG, AngelikopoulosP, HadjidoukasP, PapadimitriouC, KoumoutsakosP. Data driven inference for the repulsive exponent of the Lennard-Jones potential in molecular dynamics simulations. Sci. Rep.7(1), 1–10 (2017).
   PubMedGoogle Scholar
• Ciftja O . A result for the Coulomb electrostatic energy of a uniformly charged disk. Results Phys.7, 1674–1675 (2017).
   Web of Science ®Google Scholar
• Lobanov MY , BogatyrevaN, GalzitskayaO. Radius of gyration as an indicator of protein structure compactness. Mol. Biol.42(4), 623–628 (2008).
   Web of Science ®Google Scholar
• Miu L , BogatyrevaN, GalzitskaiaO. Radius of gyration is indicator of compactness of protein structure. Mol. Biol. (Mosk.)42(4), 701–706 (2008).
   PubMed Web of Science ®Google Scholar
• Jain SS , SureshA, PirogovaE. Effects of oscillating electric fields on conotoxin peptide conformation: a molecular dynamic simulation study. J. Mol. Graph. Model.103, 107799 (2020).
   PubMed Web of Science ®Google Scholar
• Martínez L . Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PloS ONE10(3), e0119264 (2015).
   PubMed Web of Science ®Google Scholar
• Volles MJ , LansburyPT. Zeroing in on the pathogenic form of α-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry42(26), 7871–7878 (2003).
   PubMed Web of Science ®Google Scholar
• Fagerqvist T , LindströmV, NordströmEet al. Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation. J. Neurochem.126(1), 131–144 (2013).
   PubMed Web of Science ®Google Scholar
• Wang P , WangX, WangL, HouX, LiuW, ChenC. Interaction of gold nanoparticles with proteins and cells. Sci. Technol. Adv. Mater.16(3), 034610 (2015).
   PubMed Web of Science ®Google Scholar
• Wu J , XieH. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons. Artif. Cells Nanomed. Biotechnol.44(2), 690–694 (2016).
   PubMed Web of Science ®Google Scholar
• Mohammad-Beigi H , ShojaosadatiSA, MarvianATet al. Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter α-synuclein conformation and aggregation kinetics. Nanoscale7(46), 19627–19640 (2015).
   PubMed Web of Science ®Google Scholar
• Sudhakar S , KalipillaiP, SanthoshPB, ManiE. Role of surface charge of inhibitors on amyloid beta fibrillation. J. Phys. Chem. C121(11), 6339–6348 (2017).
   Web of Science ®Google Scholar
• Lotfabadi A , HajipourMJ, DerakhshankhahHet al. Biomolecular corona dictates Aβ fibrillation process. ACS Chem. Neurosci.9(7), 1725–1734 (2018).
   PubMed Web of Science ®Google Scholar
• Derakhshankhah H , HajipourMJ, BarzegariEet al. Zeolite nanoparticles inhibit Aβ–fibrinogen interaction and formation of a consequent abnormal structural clot. ACS Appl. Mater. Interfaces8(45), 30768–30779 (2016).
   PubMed Web of Science ®Google Scholar
• Mahmoudi M , Quinlan-PluckF, MonopoliMPet al. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution. ACS Chem. Neurosci.4(3), 475–485 (2013).
   PubMed Web of Science ®Google Scholar
• Mirsadeghi S , DinarvandR, GhahremaniMHet al. Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process. Nanoscale7(11), 5004–5013 (2015).
   PubMed Web of Science ®Google Scholar
• Vashist A , KaushikA, VashistAet al. Advances in carbon nanotubes–hydrogel hybrids in nanomedicine for therapeutics. Adv. Healthc. Mater.7(9), 1701213 (2018).
   Web of Science ®Google Scholar